Adapting in vitro dual perfusion of the human placenta to soluble oxygen tensions associated with normal and pre-eclamptic pregnancy

Laboratory Investigation

Volumn 91, Issue 2, 2011, Pages 181-189

  Soydemir, Fatimah ^a   Kuruvilla, Sitara ^a   Brown, Marie ^b   Dunn, Warwick ^c   Day, Philip ^d   Crocker, Ian P ^a   Baker, Philip N ^a   Sibley, Colin P ^a   Brownbill, Paul ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b Manchester Institute of Biotechnology   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

metabolism; oxygen; perfusion; placenta; pre eclampsia

Indexed keywords

LACTATE DEHYDROGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PLACENTAL GROWTH FACTOR;

ARTICLE; CONTROLLED STUDY; FEMALE; FETUS CIRCULATION; GLUCOSE INTAKE; GLYCOLYSIS; HUMAN; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; LACTATE DEHYDROGENASE BLOOD LEVEL; OXYGEN CONCENTRATION; OXYGEN TENSION; PLACENTA PERFUSION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VEIN BLOOD FLOW;

CATHETERS; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; OXYGEN; PERFUSION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 79551601094     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.171     Document Type: Article

References (36)

1. Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol 1972;114:822-828.
2. Dancis J. Why perfuse the placenta? Contrib Gynecol Obstet 1985; 13:1-4.
3. Leach L, Eaton BM, Westcott ED, et al. Effect of histamine on endothelial permeability and structure and adhesion molecules of the paracellular junctions of perfused human placental microvessels. Microvasc Res 1995;50:323-337.
4. Brownbill P, McKeeman GC, Brockelsby JC, et al. Vasoactive and permeability effects of vascular endothelial growth factor-165 in the term in vitro dually perfused human placental lobule. Endocrinology 2007;148:4734-4744.
5. Schneider H. Placental oxygen consumption. Part II: in vitro studies-a review. Placenta 2000;21(Suppl A):S38-S44.
6. Byrne BM, Howard RB, Morrow RJ, et al. Role of the L-arginine nitric oxide pathway in hypoxic fetoplacental vasoconstriction. Placenta 1997;18:627-634.
7. Rodesch F, Simon P, Donner C, et al. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 1992;80:283-285.
8. Jauniaux E, Watson AL, Hempstock J, et al. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 2000;157:2111-2122.
9. Rollins MD, Maxwell AP, Afrasiabi M, et al. Cord blood erythropoietin, pH, PaO2 and haematocrit following caesarean section before labour. Biol Neonate 1993;63:147-152.
10. Crocker IP, Wareing M, Ferris GR, et al. The effect of vascular origin, oxygen, and tumour necrosis factor alpha on trophoblast invasion of maternal arteries in vitro. J Pathol 2005;206:476-485.
11. Borrego-D?́az E RJ, Proverbio T, Teppa-Garrán A, et al. Effect of placental hypoxia on the plasma membrane Ca-ATPase (PMCA) activity and the level of lipid peroxidation of syncytiotrophoblast and red blood cell ghosts. Placenta 2008;29:44-50.
12. Robinson NJ, Wareing M, Hudson NK, et al. Oxygen and the liberation of placental factors responsible for vascular compromise. Lab Invest 2008;88:293-305.
13. Heazell AE, Lacey HA, Jones CJ, et al. Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast. Placenta 2008;29:175-186.
14. Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update 2006;12:747-755.
15. Regnault TR, de Vrijer B, Galan HL, et al. Development and mechanisms of fetal hypoxia in severe fetal growth restriction. Placenta 2007; 28:714-723.
16. Shore VH, Wang TH, Wang CL, et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997;18:657-665.
17. Ahmed A, Dunk C, Ahmad S, et al. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (P1GF) and soluble Flt-1 by oxygen-a review. Placenta 2000;21(Suppl A): S16-S24.
18. Trollmann R, Amann K, Schoof E, et al. Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia. Am J Obstet Gynecol 2003;188:517-523.
19. Brownbill P, Mills TA, Soydemir DF, et al. Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia. Placenta 2008;29:950-955.
20. Chung JY, Song Y, Wang Y, et al. Differential expression of vascular endothelial growth factor (VEGF), endocrine galnd derived-VEGF, and VEGF receptors in human placentas from normal and pre-eclamptic pregnancies. J Clin Endocrinol Metab 2004;89:2484-2490.
21. Goodacre R, Vaidyanathan S, Dunn WB, et al. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol 2004;22:245-252.
22. Edwards D, Jones CJ, Sibley CP, et al. Paracellular permeability pathways in the human placenta: a quantitative and morphological study of maternal-fetal transfer of horseradish peroxidase. Placenta 1993;14:63-73.
23. Brownbill P, Sibley CP. Regulation of transplacental water transfer: the role of fetoplacental venous tone. Placenta 2006;27:560-567.
24. Challier JC, Schneider H, Dancis J. In vitro perfusion of human placenta. V. Oxygen consumption. Am J Obstet Gynecol 1976;126:261-265.
25. Hauguel S, Desmaizieres V, Challier JC. Glucose uptake, utilization, and transfer by the human placenta as functions of maternal glucose concentration. Pediatr Res 1986;20:269-273.
26. Mayhew TM. Stereology and the placenta: wheres the point?-A Review. Placenta 2006;27(Suppl):17-25.
27. Bachmaier N, Linnemann K, May K, et al. Ultrastructure of human placental tissue after 6 h of normoxic and hypoxic dual in vitro placental perfusion. Placenta 2007;28:861-867.
28. Howard RB, Hosokawa T, Maguire MH. Hypoxia-induced fetoplacental vasoconstriction in perfused human placental cotyledons. Am J Obstet Gynecol 1987;157:1261-1266.
29. Meschia G, Battaglia FC, Bruns PD. Theoretical and experimental study of transplacental diffusion. J Appl Physiol 1967;22:1171-1178.
30. Cannell GR, Kluck RM, Hamilton SE, et al. Markers of physical integrity and metabolic viability of the perfused human placental lobule. Clin Exp Pharmacol Physiol 1988;15:837-844.
31. Penfold P, Drury L, Simmonds R, et al. Studies of a single placental cotyledon in vitro: I. The preparation and its viability. Placenta 1981;2:149-154.
32. Schneider H, Reiber W, Sager R, et al. Asymmetrical transport of glucose across the in vitro perfused human placenta. Placenta 2003; 24:27-33.
33. VanOtteren GM, Standiford TJ, Kunkel SL, et al. Alterations of ambient oxygen tension modulate the expression of tumor necrosis factor and macrophage inflammatory protein-1 alpha from murine alveolar macrophages. Am J Respir Cell Mol Biol 1995;13:399-409.
34. Lyall F, Young A, Boswell F, et al. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997;18:269-276.
35. Baker PN, Krasnow J, Roberts JM, et al. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol 1995;86:815-821.
36. Claffey KP, Shih SC, Mullen A, et al. Identification of a human VPF/VEGF 30 untranslated region mediating hypoxia-induced mRNA stability. Mol Biol Cell 1998;9:469-481.